Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × OTHER_GOV × avelumab × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 4 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

toripalimab 1 lenvatinib 1 fludarabine 1 epigallocatechin gallate 1 avelumab 1 Zinc 1 Tissue Banks 1 Quercetin 1 Pemetrexed 1 Paclitaxel 1 Metformin 1 Interleukin-2 1 Docetaxel 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Blood Specimen Collection 1 Biopsy, Needle 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡